CDKN1A and neoplasm: In certain cancer types, such as adrenal, pancreatic, and renal, there is a significant (p < 0.01) increase in CDKN1A/p21 expression in the tumour tissue compared to normal tissue, while in others, such as AML, colon, and lung, the opposite trend is observed (Figure 2a).